The Trump administration is establishing a quarantine and treatment facility in Kenya to house U.S. citizens exposed to the Ebola virus during the current outbreak in the Democratic Republic of the Congo (DRC), officials confirmed. This marks a shift from previous practices in which Americans exposed to Ebola were repatriated to specialized treatment units within the United States.

The proposed facility, a joint effort by the Departments of Defense, State, and Health and Human Services, is expected to be operational within a week at a U.S. military air base in central Kenya. Initial plans call for a 50-bed unit with the capacity to expand to 250 beds. Patients would be cared for in biocontainment units transported from the U.S., providing quarantine and medical support without the delays associated with long-distance medical evacuations. Transporting patients back to the U.S. can involve over 12 hours of medevac flight time, which the administration aims to avoid.

Americans deemed at high risk of developing Ebola, including Public Health Service officers, are being trained at Joint Base Andrews to staff the Kenya facility. Although the center intends to provide high-quality care, patients will be evaluated for transfer to more advanced treatment centers abroad, primarily in Europe, if necessary.

The decision reflects the administration's reluctance to bring potentially infected individuals back to the United States, a policy underscored by the recent use of Title 42, a public health law invoked to restrict entry to the U.S. for immigrants and legal permanent residents who have been in Congo, Uganda, or South Sudan within the prior 21 days.

The Ebola outbreak in the DRC, primarily in Ituri Province, has rapidly escalated amid ongoing conflict and population movements, complicating containment efforts. The World Health Organization declared the situation a public health emergency of international concern, with over 900 suspected cases and more than 220 deaths reported.

While the facility in Kenya is intended to offer prompt care and reduce evacuation times, some public health experts have expressed concerns. Dr. Tom Inglesby, director of the Johns Hopkins Center for Health Security, emphasized that survival chances improve significantly with early access to specialized care, which established U.S. units have historically provided. He expressed surprise at plans not to repatriate Public Health Service officers for treatment.

Similarly, Dr. Craig Spencer, an emergency physician who treated Ebola patients during the 2014 West African outbreak, questioned whether a comparable level of care could be rapidly established in Kenya, describing the decision as a “dramatic abdication” of the United States’ responsibilities to its citizens.

In Kenya, the proposal has generated debate, with some local voices opposing the presence of Ebola-exposed Americans due to fears of virus spread, although Kenyan authorities have approved the construction of the facility. The U.S. is reportedly still awaiting permission to transfer patients into the country.

The current Bundibugyo strain of Ebola circulating in the DRC has no approved vaccine or specific therapeutic treatment, further complicating clinical management. The administration’s approach underscores a strategic shift focusing on rapid isolation and containment abroad rather than lengthy medical evacuations to the United States.